Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Cambridge Innovation Capital
About
CIC backs life sciences and technology companies in Europe’s leading ecosystem, Cambridge. A preferred investor for the university.
- Cambridge,Cambridgeshire,United Kingdom
- https://www.cic.vc/
Details
- Last Funding Type
- Secondary Market
- Industries
- Finance,Financial Services,Intellectual Property,Venture Capital
- Founded date
- Jan 1, 2013
- Operating Status
- Active
- Legal Name
- CIC Ltd
- Also Known As
- CIC
- Investor Type
- Venture Capital
Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem.Since our inception in 2013, we have raised £275 million to invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 18, 2021 | Secondary Market | — | 1 | — | — | Detail |
| Aug 19, 2016 | Series Unknown | $75M | 7 |
University of Cambridge
|
— | Detail |
Funds Raised
| Announced Date | Fund Name | Money Raised | |
|---|---|---|---|
| Apr 26, 2022 | Fund II | €264M | |
| Apr 1, 2019 | Cambridge Innovation Capital plc | £275M |
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 14, 2022
Storm Therapeutics
|
Series B | $30M | Biotechnology | Yes |
|
Dec 1, 2022
Carrick Therapeutics
|
Series C | $60M | Biotechnology | — |
|
Nov 11, 2022
Cambridge GaN Devices
|
Series B | $19M | Semiconductor | — |
|
Sep 12, 2022
Pretzel Therapeutics
|
Series A | $72.50M | Biotechnology | — |
|
Sep 12, 2022
Unlikely AI
|
Seed | £17.40M | Artificial Intelligence | — |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
University of Cambridge
|
Yes | Series Unknown |
|
|
— | Secondary Market |
Arm Holdings
|
— | Series Unknown |
IP Group
|
— | Series Unknown |
Lansdowne Partners
|
— | Series Unknown |
Oman Investment Fund
|
— | Series Unknown |
Winton Ventures
|
— | Series Unknown |
Woodford Investment Management
|
— | Series Unknown |
Employee Profiles
Exits
Cambridge Innovation Capital has had 7 exits. Cambridge Innovation Capital most notable exits include Sense Biodetection , Audio Analytic
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Feb 1, 2023 | Sense Biodetection | M&A | Health Care | Detail |
| Nov 8, 2022 | Audio Analytic | M&A | Audio | Detail |
| Sep 28, 2022 | Abcodia | M&A | Biotechnology | Detail |
| Dec 22, 2021 | Gyroscope Therapeutics | M&A | Biotechnology | Detail |
| May 5, 2021 | Inivata | M&A | Biotechnology | Detail |
